MA41198A - Essais d'activité enzymatique pour i2s - Google Patents

Essais d'activité enzymatique pour i2s

Info

Publication number
MA41198A
MA41198A MA041198A MA41198A MA41198A MA 41198 A MA41198 A MA 41198A MA 041198 A MA041198 A MA 041198A MA 41198 A MA41198 A MA 41198A MA 41198 A MA41198 A MA 41198A
Authority
MA
Morocco
Prior art keywords
enzymatic activity
activity tests
tests
enzymatic
activity
Prior art date
Application number
MA041198A
Other languages
English (en)
Inventor
Peter Bernhardt
Vijay Chhajlani
Elisha Fielding
Claire Tien
Original Assignee
Shire Human Genetic Therapies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Human Genetic Therapies filed Critical Shire Human Genetic Therapies
Publication of MA41198A publication Critical patent/MA41198A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA041198A 2014-12-18 2015-12-16 Essais d'activité enzymatique pour i2s MA41198A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462093826P 2014-12-18 2014-12-18

Publications (1)

Publication Number Publication Date
MA41198A true MA41198A (fr) 2017-10-24

Family

ID=55083510

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041198A MA41198A (fr) 2014-12-18 2015-12-16 Essais d'activité enzymatique pour i2s

Country Status (4)

Country Link
US (1) US20170362632A1 (fr)
EP (1) EP3234175A1 (fr)
MA (1) MA41198A (fr)
WO (1) WO2016100603A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018191666A1 (fr) * 2017-04-14 2018-10-18 Regenxbio Inc. Traitement de la mucopolysaccharidose ii avec l'iduronate-2-sulfatase (ids) humaine recombinée produite par des cellules neurales ou gliales humaines
MA50746A (fr) 2017-10-02 2020-08-12 Denali Therapeutics Inc Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive
WO2020050947A2 (fr) * 2018-09-05 2020-03-12 Sangamo Therapeutics, Inc. Dosages enzymatiques pour quantifier une thérapie chez des sujets atteints de mucopolysaccharidose de type i ou ii
US20200071743A1 (en) * 2018-09-05 2020-03-05 Sangamo Therapeutics, Inc. Enzymatic assays for quantifying therapy in subjects with mucopolysaccharidosis type i or ii
EP3826664A4 (fr) 2019-02-06 2022-10-26 Sangamo Therapeutics, Inc. Procédé de traitement des mucopolysaccharidoses de type i
WO2022173605A2 (fr) 2021-02-10 2022-08-18 Regenxbio Inc. Traitement de la mucopolysaccharidose ii avec de l'iduronate-2-sulfatase (ids) humaine recombinée

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650270A (en) 1982-02-01 1997-07-22 Northeastern University Molecular analytical release tags and their use in chemical analysis
US5516931A (en) 1982-02-01 1996-05-14 Northeastern University Release tag compounds producing ketone signal groups
US4709016A (en) 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4650750A (en) 1982-02-01 1987-03-17 Giese Roger W Method of chemical analysis employing molecular release tag compounds
SI2325302T1 (sl) 2003-02-11 2016-05-31 Shire Human Genetic Therapies, Inc. Celice, ki soizražajo sulfatazo in c-formilglicin generirajoči encim ter postopki in uporabe le-teh
US8202686B2 (en) * 2007-03-22 2012-06-19 Advanced Liquid Logic, Inc. Enzyme assays for a droplet actuator
WO2012101671A1 (fr) * 2011-01-25 2012-08-02 Jcr Pharmaceuticals Co., Ltd. Procédé de production d'iduronate 2-sulfatase recombinante humaine
WO2013070953A1 (fr) * 2011-11-08 2013-05-16 University Of Washington Procédés et compositions d'analyse d'enzymes lysosomales
EP2700717B1 (fr) * 2012-08-22 2016-06-01 Przybylski, Michael Procédé pour le diagnostic de maladies de stockage lysosomal

Also Published As

Publication number Publication date
WO2016100603A1 (fr) 2016-06-23
EP3234175A1 (fr) 2017-10-25
WO2016100603A9 (fr) 2016-08-11
US20170362632A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
FR24C1022I2 (fr) Modulation d'activité du complément
EP3347458A4 (fr) Cochon multi-transgénique pour xénogreffe
EP3384070A4 (fr) Procédé d'amélioration de l'activité catalytique
EP3630078A4 (fr) Agents pour chimio-embolisation
EP3005828A4 (fr) Bsr et lcp pour double connectivité
FI20155065A7 (fi) Monikäyttölaite eläimen hoitoon
DK3190923T3 (da) Hovedstøtte
EP3250230A4 (fr) Modulateurs d'activité du complément
EP3324925A4 (fr) Formulations topiques pour la peau
MA51554A (fr) Anticorps il-6 améliorés
MA50533A (fr) Imipridones pour gliomes
PT3092003T (pt) Novo anticorpo anti-netrina 1
MA41198A (fr) Essais d'activité enzymatique pour i2s
EP3337485A4 (fr) Formes cristallines d'ibrutinib
EP3261631A4 (fr) Inhibition de l'activité d'olig2
EP3359556A4 (fr) Modulation de l'activité des cytokines gamma-c
HUE060732T2 (hu) Terápiás szer fibrózisra
EP3730141A4 (fr) Agent thérapeutique pour la pollakiurie nocturne
EP3515359A4 (fr) Attelle pour animal
EP3504195A4 (fr) Inhibition de l'activité d'olig2
HRP20181840T1 (hr) Bimatoprost oftalmološki gel u obliku kapi
EP3718568A4 (fr) Modulateur d'activité
IL252191A0 (en) Compositions and methods for modulating at2r activity
FR3029422B1 (fr) Microbille d'hydrogel
DK3185678T3 (da) Grisemodel for diabetes